Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

被引：0
|
作者：
Hizal, Mutlu [1 ]
Sendur, Mehmet A. N. [2 ]
Yalcin, Bulent [2 ]
机构：
[1] Ankara City Hosp, Ankara, Turkey
[2] Yildirim Beyazit Univ, Ankara, Turkey
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：694 / 694
页数：1
相关论文
共 50 条
  • [1] Atezolizumab/Bevacizumab in hepatocellular carcinoma
    Kuetting, Fabian
    Alakus, Hakan
    Bruns, Christiane
    ONKOLOGE, 2020, 26 (10): : 970 - 971
  • [2] Atezolizumab and Bevacizumab in Hepatocellular Carcinoma REPLY
    Finn, Richard S.
    Cheng, Ann-Lii
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 695 - 695
  • [3] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Qin, Shukui
    Ikeda, Masafumi
    Galle, Peter R.
    Ducreux, Michel
    Kim, Tae-You
    Kudo, Masatoshi
    Breder, Valeriy
    Merle, Philippe
    Kaseb, Ahmed O.
    Li, Daneng
    Verret, Wendy
    Xu, Derek-Zhen
    Hernandez, Sairy
    Liu, Juan
    Huang, Chen
    Mulla, Sohail
    Wang, Yulei
    Lim, Ho Yeong
    Zhu, Andrew X.
    Cheng, Ann-Lii
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1894 - 1905
  • [4] Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
    Lee, Kyung-Hun
    Lee, Michael S.
    LANCET ONCOLOGY, 2020, 21 (09): : E413 - E413
  • [5] Atezolizumab/Bevacizumab beim hepatozellulären KarzinomAtezolizumab/Bevacizumab in hepatocellular carcinoma
    Fabian Kütting
    Hakan Alakus
    Christiane Bruns
    Der Onkologe, 2020, 26 (10): : 970 - 971
  • [6] Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
    Suga, Takayoshi
    Kimura, Yuko
    Furuya, Kensuke
    Sato, Hiroko
    CLINICAL CASE REPORTS, 2023, 11 (09):
  • [7] Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma
    D'Alessio, Antonio
    Cammarota, Antonella
    Zanuso, Valentina
    Pressiani, Tiziana
    Personeni, Nicola
    Rimassa, Lorenza
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (09) : 927 - 939
  • [8] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Moris, Dimitrios
    JOURNAL OF BUON, 2021, 26 (02): : 637 - 638
  • [9] Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular Carcinoma
    Castet, Florian
    Willoughby, Catherine E.
    Haber, Philipp K.
    Llovet, Josep M.
    CLINICAL CANCER RESEARCH, 2021, 27 (07) : 1827 - 1829
  • [10] PREDICTING RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA
    Cappuyns, Sarah
    Pique-Gili, Marta
    Esteban-Fabro, Roger
    Philips, Gino
    Pinyol, Roser
    Vandecaveye, Vincent
    Abril-Fornaguera, Jordi
    Haber, Philipp
    Verslype, Chris
    Van Cutsem, Eric
    Lambrechts, Diether
    Villanueva, Augusto
    Dekervel, Jeroen
    Llovet, Josep M.
    HEPATOLOGY, 2023, 78 : S1871 - S1872
12345